BioMarin Pharmaceuticals
BMRN
BMRN
459 hedge funds and large institutions have $17.6B invested in BioMarin Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 45 funds opening new positions, 173 increasing their positions, 156 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
2% more capital invested
Capital invested by funds: $17.2B → $17.6B (+$356M)
1.51% less ownership
Funds ownership: 103.51% → 102% (-1.5%)
25% less funds holding in top 10
Funds holding in top 10: 12 → 9 (-3)
Holders
459
Holding in Top 10
9
Calls
$131M
Puts
$122M
Top Buyers
| 1 | +$204M | |
| 2 | +$97.2M | |
| 3 | +$84.3M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$61M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$60.6M |
Top Sellers
| 1 | -$198M | |
| 2 | -$107M | |
| 3 | -$94.2M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$78.5M |
| 5 |
Jennison Associates
New York
|
-$72.2M |